Refining prognosis in BCR-ABL1 - Positive ALL

Elizabeth A. Raetz; William L. Carroll

doi:10.1182/blood-2014-01-547570

Refining prognosis in BCR-ABL1 - Positive ALL

Elizabeth A. Raetz, William L. Carroll

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Abstract

In this issue of Blood, van der Veer et al report the negative prognostic impact of IKZF1 deletions in children with BCR-ABL1 - positive acute lymphoblastic leukemia (ALL), despite the use of tyrosine kinase inhibitor (TKI) therapy.

Original language	English
Pages (from-to)	1626-1627
Number of pages	2
Journal	Blood
Volume	123
Issue number	11
DOIs	https://doi.org/10.1182/blood-2014-01-547570
State	Published - 13 Mar 2014
Externally published	Yes

Access to Document

10.1182/blood-2014-01-547570

Cite this

@article{bc7c95599c5044fb9fe4eb0f10476e1f,

title = "Refining prognosis in BCR-ABL1 - Positive ALL",

abstract = "In this issue of Blood, van der Veer et al report the negative prognostic impact of IKZF1 deletions in children with BCR-ABL1 - positive acute lymphoblastic leukemia (ALL), despite the use of tyrosine kinase inhibitor (TKI) therapy.",

author = "Raetz, {Elizabeth A.} and Carroll, {William L.}",

year = "2014",

month = mar,

day = "13",

doi = "10.1182/blood-2014-01-547570",

language = "English",

volume = "123",

pages = "1626--1627",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "11",

}

TY - JOUR

T1 - Refining prognosis in BCR-ABL1 - Positive ALL

AU - Raetz, Elizabeth A.

AU - Carroll, William L.

PY - 2014/3/13

Y1 - 2014/3/13

N2 - In this issue of Blood, van der Veer et al report the negative prognostic impact of IKZF1 deletions in children with BCR-ABL1 - positive acute lymphoblastic leukemia (ALL), despite the use of tyrosine kinase inhibitor (TKI) therapy.

AB - In this issue of Blood, van der Veer et al report the negative prognostic impact of IKZF1 deletions in children with BCR-ABL1 - positive acute lymphoblastic leukemia (ALL), despite the use of tyrosine kinase inhibitor (TKI) therapy.

UR - http://www.scopus.com/inward/record.url?scp=84897481699&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-01-547570

DO - 10.1182/blood-2014-01-547570

M3 - Comment/debate

C2 - 24627518

AN - SCOPUS:84897481699

SN - 0006-4971

VL - 123

SP - 1626

EP - 1627

JO - Blood

JF - Blood

IS - 11

ER -

Refining prognosis in BCR-ABL1 - Positive ALL

Abstract

Access to Document

Fingerprint

Cite this